Form 8-K Beam Therapeutics Inc. For: Feb 27

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Form 8-K Beam Therapeutics Inc. For: Feb 27

Beam Therapeutics Inc (BEAM) PT Raised to $44 at JPMorgan

February 27, 2024 12:03 PM EST

JPMorgan analyst Eric Joseph raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $44.00 (from $40.00) while maintaining a Overweight rating.

The analyst comments "Beam reported a 4Q23 earnings per share of $1.73 (FY23 loss per share of $1.72), while reiterating anticipated timelines regarding key data catalysts in 2024 for both BEAM-101 (SCD) and BEAM-302 (AATD) detailed at our Healthcare Conference. For BEAM-101 in SCD, having... More